Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats.
The aim of the present work was to study the potential involvement of melanocortin system in the anorectic mechanism of fluoxetine, a selective serotonin reuptake inhibitors, in obese Zucker rats. Male obese Zucker (fa/fa) rats were administered fluoxetine (10 mg/kg; i.p.) daily for two weeks. The control group was given 0.9% NaCl solution. RT-PCR for pro-opiomelanocortin (POMC), Agouti gene related peptide (AgRP) and melanocortin receptor 4 (MC4-R) in the hypothalamus, as well as regional immunostaining for alpha-melanocyte stimulating hormone (alpha-MSH) and MC4-R were carried out. Fluoxetine administration increased POMC expression and reduced MC4-R expression in the hypothalamus, without changes in AgRP mRNA levels. Moreover, an increase in the numbers of alpha-MSH positively immunostained neural cells in the hypothalamic arcuate nucleus (ARC), as well as a significant decrease in the numbers of neural cells positively immunostained for MC4-R in the paraventricular nucleus (PVN), without changes in lateral hypothalamic area (LHA), were observed. These results suggest the involvement of alpha-MSH in central fluoxetine anorectic action.
Churruca
I
I
Department of Nutrition and Food Science, University of the Basque Country, Paseo de la Universidad 7, Vitoria, Spain. itziar.txurruka@ehu.es
Portillo
M P
MP
Casis
L
L
Gutiérrez
A
A
Macarulla
M T
MT
Echevarría
E
E
D054369:Agouti-Related Protein / Q000378:metabolism; D000818:Animals; D001067:Appetite Depressants; D001835:Body Weight / Q000187:drug effects; D017931:DNA Primers; D004435:Eating / Q000187:drug effects; D005473:Fluoxetine / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D009765:Obesity / Q000378:metabolism*; D011333:Pro-Opiomelanocortin / Q000096:biosynthesis / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis / Q000302:isolation & purification; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D044105:Receptor, Melanocortin, Type 4 / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D000521:alpha-MSH / Q000096:biosynthesis / Q000378:metabolism*
D054369:Agouti-Related Protein; D001067:Appetite Depressants; D017931:DNA Primers; D005473:Fluoxetine; D011333:Pro-Opiomelanocortin; D012313:RNA; D012333:RNA, Messenger; D044105:Receptor, Melanocortin, Type 4; D017367:Selective Serotonin Reuptake Inhibitors; D000521:alpha-MSH; C515197:AGRP protein, rat